Literature DB >> 1600332

Successful treatment of recurrent hepatic Candida infection with fluconazole after chemotherapy for acute leukemia: a case report.

T Propst1, W Vogel, A Propst, O Dietze, H Braunsteiner.   

Abstract

Hepatic candidiasis represents an increasingly difficult problem in immunocompromised patients. It has been recognized as a variant of disseminated candidiasis after a period of neutropenia. Establishment of diagnosis is difficult since liver biopsy as well as culture may be negative, in spite of the presence of fungus. Hepatic lesions are generally not detectable by ultrasound examination or computed tomography until the neutrophil count has returned to normal. The aim of this case report is to describe the problems related to the diagnosis and treatment of hepatic candidiasis following chemotherapy for acute leukemia. The report also provides further evidence that fluconazole, a new broad-spectrum antifungal drug, can be safely and effectively used for the long-term treatment of deep-seated hepatic candidiasis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600332     DOI: 10.1007/bf00422941

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  9 in total

1.  Fungal infection and fever of unknown origin in neutropenic patients.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1986-05-30       Impact factor: 4.965

2.  Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults.

Authors:  D Hoelzer; E Thiel; H Löffler; H Bodenstein; L Plaumann; T Büchner; D Urbanitz; P Koch; H Heimpel; R Engelhardt
Journal:  Blood       Date:  1984-07       Impact factor: 22.113

3.  Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia.

Authors:  B S Kramer; P A Pizzo; K J Robichaud; F Witesbsky; R Wesley
Journal:  Am J Med       Date:  1982-04       Impact factor: 4.965

4.  Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.

Authors:  P A Pizzo; K J Robichaud; F A Gill; F G Witebsky
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

5.  Candida colonization and systemic infection in neutropenic patients. A retrospective study.

Authors:  P Martino; C Girmenia; M Venditti; A Micozzi; S Santilli; V L Burgio; F Mandelli
Journal:  Cancer       Date:  1989-11-15       Impact factor: 6.860

6.  Hepatic candidiasis: an increasing problem in immunocompromised patients.

Authors:  E Haron; R Feld; P Tuffnell; B Patterson; R Hasselback; A Matlow
Journal:  Am J Med       Date:  1987-07       Impact factor: 4.965

7.  Candidiasis in cancer patients.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

Review 8.  Hepatic candidiasis in cancer patients: the evolving picture of the syndrome.

Authors:  M Thaler; B Pastakia; T H Shawker; T O'Leary; P A Pizzo
Journal:  Ann Intern Med       Date:  1988-01       Impact factor: 25.391

9.  Granulomatous hepatitis due to Candida albicans in patients with acute leukemia.

Authors:  J M Jones
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

  9 in total
  2 in total

1.  Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

Authors:  D Debruyne
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of fluconazole.

Authors:  D Debruyne; J P Ryckelynck
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.